Financials in USD. Standardized financial statements.
A compact view of how iBio, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $400,000 | $225,000 | $0 | $1.88M | $2.37M | $1.64M | $2.02M | $444,000 | $394,000 | $948,000 |
| Revenue Growth? | +77.8% | 0.0% | -100.0% | -20.5% | +44.7% | -18.8% | +354.5% | +12.7% | -58.4% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $3.79M | $1.46M | $703,000 | $0 | $0 | $0 | $0 |
| Gross Profit? | $400,000 | $225,000 | $0 | -$1.91M | $909,000 | $935,000 | $2.02M | $444,000 | $394,000 | $948,000 |
| Gross Margin? | +100.0% | +100.0% | 0.0% | -101.2% | +38.3% | +57.1% | +100.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $19.00M | $16.86M | $29.34M | $27.79M | $32.02M | $14.94M | $17.81M | $14.67M | $14.67M | $10.84M |
| Operating Income? | -$18.60M | -$16.63M | -$29.34M | -$29.70M | -$31.11M | -$14.00M | -$15.79M | -$14.23M | -$14.27M | -$9.89M |
| EBITDA? | -$17.04M | -$14.02M | -$27.85M | -$25.72M | -$28.55M | -$11.74M | -$13.95M | -$12.48M | -$12.53M | -$8.91M |
| Income Before Tax | -$18.38M | -$15.44M | -$29.31M | -$29.51M | -$23.21M | -$16.44M | -$17.60M | -$16.11M | -$14.53M | -$10.66M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$4,000 | $34,000 | $347,000 | -$65,000 |
| Net Income? | -$18.38M | -$24.91M | -$65.01M | -$50.39M | -$23.21M | -$16.44M | -$17.59M | -$16.11M | -$14.53M | -$9.76M |
| EPS? | $-1.75 | $-6.50 | $-106.18 | $-2889.06 | $-59.98 | $-304.64 | $-471.65 | $-770.00 | $-800.00 | $-600.00 |
| Diluted EPS? | $-1.75 | $-6.50 | $-106.18 | $-2889.06 | $-59.98 | $-304.64 | $-471.65 | $-770.00 | $-800.00 | $-600.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality